How Irani was paid
$285,450 in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Other | Total |
|---|---|---|---|---|
| Zackary IraniChief Executive Officer and Director | $150,000 | $135,450 | — | $285,450 |
| Allen BarbieriDirector, Executive Vice-Chairperson of the Board and Corporate Secretary | $88,000 | $77,400 | — | $165,400 |
| Gary LuChief Financial Officer | $233,454 | $103,200 | $50,000 | $386,654 |
What changed and why
- No management incentive cash bonus was paid to any named executive for fiscal 2026.
- $150K$150,000 was Irani’s annual base salary after reinstatement effective January 1, 2025.
- $135K$135,450 in restricted stock awards was granted to Irani; the awards vest in four annual installments beginning December 12, 2026.
- $77,400$77,400 in restricted stock awards was granted to Barbieri; the awards cliff vest on December 12, 2026.
- $50,000$50,000 for Lu’s accrued unused paid time off was included in All Other Compensation; his unvested stock awards were forfeited after resignation.
Other Biomerica proxy statements
- 2025 proxy statement
Zackary Irani paid $201,034 (-44% on the year).
Filed Oct 20, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.